This Black History Month, we’re centering the voices, stories, and experiences of Black lupus warriors. Throughout February, we’re sharing resources and community spaces designed to support and ...

A new study exploring the investigational therapy, Zorpo-cel, met its primary safety and secondary efficacy endpoints in people with progressive and treatment-resistant systemic sclerosis (SSc), ...

The U.S. Food and Drug Administration (FDA) issued a complete response letter requesting additional information from AstraZeneca regarding the Biologics License Application (BLA) for subcutaneous (SC) ...

Congress has taken the final steps in the FY 2026 budget process, passing legislation that increases funding for lupus programs, including $27 million - the most in history - for lupus programs at the ...

Learn more about how your company or organization can raise its profile and morale by becoming a corporate partner.

Black History Month serves as a reminder to actively amplify Black voices, share stories and raise awareness throughout the year. This month, we’re featuring Danielle Storr, a Black lupus warrior who ...

A new groundbreaking study has recently identified the link between the long-standing mystery in autoimmune disease: Epstein-Barr Virus (EBV) and how it contributes towards the development of systemic ...

The physical, emotional and financial toll of lupus can be invisible to those who don’t live with this disease. Lupus symptoms affect each person differently, and it can be difficult for those without ...

Inflammation usually happens when your immune system is fighting an infection or injury. It’s a normal part of your body’s healing process. But when you have an autoimmune disease like lupus, your ...

The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...

The 340B Drug Pricing Program was started in 1992 by Congress to help offset the costs of providing medications to low-income patients by allowing certain hospitals to purchase prescription drugs at ...